The Ministry of Health has refuted reports of a reduction in antiretroviral (ARV) drug supplies, assuring the public that HIV treatment remains available and free in all public and Private Not-For-Profit (PNFP) health facilities.
In a statement released on 20th March 2025, the ministry dismissed an article published by one of the newspapers on 18th March 2025, titled "Panic as HIV Drug Supply Reduces," calling it misleading and inaccurate.
“The assertions in this article are exaggerated and misrepresent the actual status of ARV drug availability in Uganda, thereby causing unnecessary fear and anxiety among the public,” said Dr. Charles Olaro, the Acting Director General of Health Services.
The ministry reaffirmed that ARVs are consistently supplied through the National Medical Stores (NMS) and Joint Medical Stores (JMS) to over 2,000 health facilities every two months. No stockouts have been reported in the past two years.
Additionally the statement noted, Uganda’s local pharmaceutical industry continues to grow, with WHO-prequalified drug production at Quality Chemicals Uganda Limited in Luzira, Kampala. Since 2023, the company has been manufacturing ARVs and anti-malarial medicines for both local and international markets.
The government is also implementing a patient-centered healthcare model, integrating HIV/AIDS, TB, Hepatitis B, hypertension, and diabetes treatment into routine outpatient and chronic care services to improve efficiency.
The Ministry of Health urged media houses to verify information before publication to prevent unnecessary panic. “Misinformation on critical health matters can hinder national HIV/AIDS response efforts. We call for responsible journalism that aligns with our shared goal of protecting public health,” the statement read.
Uganda remains committed to ensuring access to HIV prevention, care, and treatment services. Currently, 1.4 million people are on antiretroviral treatment, with the country achieving an 89% viral suppression rate. The government encourages all people living with HIV to continue utilizing these essential services.
Dr. Olaro reaffirmed Uganda’s commitment to a steady ARV supply, stating that the National HIV and AIDS Strategic Plan 2020/21–2024/25 prioritizes uninterrupted treatment for all patients.
